A RETROSPECTIVE STUDY ON THE OUTCOMES OF PNEUMATIC VITREOLYSIS FOR THE TREATMENT OF VITREOMACULAR TRACTION.

IF 2.3 2区医学 Q2 OPHTHALMOLOGY Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2024-10-22 DOI:10.1097/IAE.0000000000004319

Ivo De Clerck, Juliette Bivort, Joachim Van Calster, Peter Stalmans

{"title":"A RETROSPECTIVE STUDY ON THE OUTCOMES OF PNEUMATIC VITREOLYSIS FOR THE TREATMENT OF VITREOMACULAR TRACTION.","authors":"Ivo De Clerck, Juliette Bivort, Joachim Van Calster, Peter Stalmans","doi":"10.1097/IAE.0000000000004319","DOIUrl":null,"url":null,"abstract":"Purpose: To study the effectiveness and safety of pneumatic vitreolysis (PVL) for the treatment of symptomatic vitreomacular traction (VMT) and macular holes (MHs) with VMT.Methods: This was a retrospective, monocentric analysis of 92 consecutive VMT (±MH) patients treated with PVL at University Hospitals Leuven between January 2022 and March 2024.Results: Release of VMT occurred in 60% of the patients who had VMT and in 86% of the patients who had MHs. MH closure occurred in 29% of the small MHs. Lens status was the only predictor of VMT release, with an odds ratio of 0.232 for pseudophakia (p = 0.013). Successful PVL was associated with significant improvements in the best-corrected visual acuity (BCVA) in patients with VMT (p = 0.007) and in patients with MHs (p = 0.034). Two patients (2.2%) suffered a retinal tear, one of which led to retinal detachment. Two patients with VMT (3.17%) developed a MH.Conclusions: PVL using the injection of 0.2 cc of C2F6 and subsequent posturing appears to be beneficial with limited complications for symptomatic focal VMT and for (very) small MHs with VMT, especially in phakic patients. The complication rate in this study was lower than that previously reported.","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retina-The Journal of Retinal and Vitreous Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/IAE.0000000000004319","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To study the effectiveness and safety of pneumatic vitreolysis (PVL) for the treatment of symptomatic vitreomacular traction (VMT) and macular holes (MHs) with VMT.

Methods: This was a retrospective, monocentric analysis of 92 consecutive VMT (±MH) patients treated with PVL at University Hospitals Leuven between January 2022 and March 2024.

Results: Release of VMT occurred in 60% of the patients who had VMT and in 86% of the patients who had MHs. MH closure occurred in 29% of the small MHs. Lens status was the only predictor of VMT release, with an odds ratio of 0.232 for pseudophakia (p = 0.013). Successful PVL was associated with significant improvements in the best-corrected visual acuity (BCVA) in patients with VMT (p = 0.007) and in patients with MHs (p = 0.034). Two patients (2.2%) suffered a retinal tear, one of which led to retinal detachment. Two patients with VMT (3.17%) developed a MH.

Conclusions: PVL using the injection of 0.2 cc of C2F6 and subsequent posturing appears to be beneficial with limited complications for symptomatic focal VMT and for (very) small MHs with VMT, especially in phakic patients. The complication rate in this study was lower than that previously reported.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

气动玻璃体溶解术治疗玻璃体白膜牵引效果的回顾性研究。

目的：研究气动玻璃体溶解术（PVL）治疗无症状玻璃体粘膜牵引（VMT）和伴有VMT的黄斑孔（MH）的有效性和安全性：这是对2022年1月至2024年3月期间在鲁汶大学医院接受PVL治疗的92例连续VMT（±MH）患者的回顾性单中心分析：60%的 VMT 患者和 86% 的 MH 患者的 VMT 得到释放。29%的小MH发生了MH闭合。晶状体状态是 VMT 释放的唯一预测因素，假性角膜的几率为 0.232（p = 0.013）。成功的 PVL 与 VMT 患者（p = 0.007）和 MHs 患者（p = 0.034）的最佳矫正视力（BCVA）显著改善有关。两名患者（2.2%）出现视网膜撕裂，其中一人导致视网膜脱离。两名 VMT 患者（3.17%）出现了 MH：注射 0.2 毫升 C2F6 并随后进行体位调整的 PVL 似乎对有症状的局灶性 VMT 和伴有 VMT 的（极小）MH 有益，但并发症有限，尤其是在法眼患者中。本研究的并发症发生率低于之前的报道。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Retina-The Journal of Retinal and Vitreous Diseases 医学-眼科学

CiteScore

5.70

自引率

9.10%

发文量

554

审稿时长

3-6 weeks

期刊介绍： RETINA® focuses exclusively on the growing specialty of vitreoretinal disorders. The Journal provides current information on diagnostic and therapeutic techniques. Its highly specialized and informative, peer-reviewed articles are easily applicable to clinical practice. In addition to regular reports from clinical and basic science investigators, RETINA® publishes special features including periodic review articles on pertinent topics, special articles dealing with surgical and other therapeutic techniques, and abstract cards. Issues are abundantly illustrated in vivid full color. Published 12 times per year, RETINA® is truly a “must have” publication for anyone connected to this field.